Sudsawat Laohavinij

A Phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid

Sudsawat Laohavinij, Stephen R. Wedge, Micheal J. Lind et al. · Investigational New Drugs · 1996 · 50 citations

Medicine, Pharmacology, Pharmacotherapy +3

A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide

Piyawan Tienchaiananda, Wipada Nipondhkit, Kunlatida Maneenil et al. · Annals of Palliative Medicine · 2019 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prognostic factors for survival in colorectal cancer patients.

Sudsawat Laohavinij, Jedzada Maneechavakajorn, Parapat Techatanol · PubMed · 2010 · 37 citations

Medicine, Oncology, Surgery +17

Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplement.

Stephen R. Wedge, Sudsawat Laohavinij, G. A. Taylor et al. · PubMed · 1995 · 22 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer

Sudsawat Laohavinij, S Maoleekoonpairoj, A Cheirsilpa et al. · Lung Cancer · 1999 · 21 citations

Medicine, Oncology, Pharmacology +13